<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>diseases on</title><link>https://notes.beauhilton.com/tags/diseases/</link><description>Recent content in diseases on</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><atom:link href="https://notes.beauhilton.com/tags/diseases/index.xml" rel="self" type="application/rss+xml"/><item><title>HPV+ OPSCC incidence over time</title><link>https://notes.beauhilton.com/notes/HPV+-OPSCC-incidence-over-time/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://notes.beauhilton.com/notes/HPV+-OPSCC-incidence-over-time/</guid><description>&amp;ldquo;&amp;hellip;overall HPV prevalence in OPSCC is increasing significantly over time:
from 40.5% before 2000, to 64.3% between 2000 and 2004, and 72.</description></item><item><title>{{Acute Lymphoblastic Leukemia}}</title><link>https://notes.beauhilton.com/notes/lectures/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://notes.beauhilton.com/notes/lectures/</guid><description>ALL 2022-07-26 Kate Baker intro 2022-08-03 Vivek Patel mgmt
overview of ALL PB flow: MPO -ve, TDT+, look for CD19, CD20, CD22 (see tx below)</description></item></channel></rss>